| Investor Relations and Shareholders Communication
The Board recognises the importance of maintaining effective
communication, ensuring timely and accurate disclosure of
information to the shareholders and investors of the Group.
Besides the information communicated through the annual report,
various announcements on significant events are made throughout
the year and quarterly financial results are announced via Bursa
Malaysia Securities Berhad's website (www.bursamalaysia.com) to
ensure shareholders are appraised with up-to-date overview of the
Group's performance and operations.
General Meetings
The Annual General Meeting ("AGM") is the principal forum for
dialogue and interaction with shareholders of the Group. Notice of
the AGM and annual reports are sent out to the shareholders at
least 21 days before the date of the meeting. At each AGM, the
Board presents the progress and performance of the business and
encourages shareholders to participate in the question and answer
session or to seek clarification on the Company's performance and
business climate. All members of the Board as well as the external
auditors of the Group and Management are available to respond to
shareholders' queries raised at the meeting.
Extraordinary General Meeting ("EGM") are held as and when
required. In addition, a press conference is normally held after the
AGM, at which members of the press are encouraged to ask the
Chairman and Chief Executive Officer questions on a range of
topics relevant to the Group.
Investor Relations
Continuous briefing for members of the media, fund managers,
institutional investors and investment analysts are held to provide
updates on key events and latest developments of the Group. The
Group's corporate website, www.duopharma.com.my, provides
an avenue for dissemination of up-to-date information such as
corporate information, financial information, press releases, share
price history and other relevant news on the Group.
Annual Report
The Directors believe that an important channel to reach
shareholders and investors is through the Annual Report. Besides
including comprehensive financial performance and information on
the business activities, the Group strives to improve the contents
of the Annual Report in line with the developments in corporate
governance practices.
The Company's Annual Report can be obtained by accessing the
Group's website at www.duopharma.com.my.
Announcement of Quarterly Results for the Financial Year Ended 31 December 2009
The Directors view the timely announcement of the quarterly
financial results as vital to the dissemination of information to
the shareholders and investors community. The Group has
consistently announced its quarterly results before the Bursa
Malaysia¡¯s deadlines as indicated below:
| Announcement of Quarterly Results 2009 |
Date of Announcement |
| 1st Quarter |
26 May 2009 |
| 2nd Quarter |
26 August 2009 |
| 3rd Quarter |
20 November 2009 |
| 4th Quarter |
23 February 2010 |
Continuing Disclosure of Material Information
The Group has long observed the continuing disclosure obligation
imposed upon a listed issuer by Bursa Malaysia. The Company
has consistently adopted and applied the principles of best
practices in Corporate Disclosure Policy and Procedures as laid
down by Bursa Malaysia.
The following material information and the material development
thereof have been released to shareholders via Bursa Malaysia
on a timely basis:
- News Release on the investment of RM75 million for a three
year plant expansion from 2008 to 2010 as part of the
Group's growth strategies;
- Proposed disposal of vacant freehold industrial land of Lot
No. 2555 and Lot No. 2556, Mukim and District of Klang,
State of Selangor to Himpun Menang Sdn Bhd for a total
purchase consideration of RM8,131,149.90
|
